Bundamedik Tbk PT (BMHS) — Cash Flow-to-Debt Ratio
Bundamedik Tbk PT (BMHS) has a Cash Flow-to-Debt Ratio of 0.12x as of December 2025, meaning its operating cash flow of Rp199.64 Billion could theoretically repay 0% of its total liabilities (Rp1.62 Trillion) in one year. See BMHS free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Bundamedik Tbk PT Cash Flow-to-Debt Ratio (2018–2025)
Historical debt coverage capacity for Bundamedik Tbk PT across 8 annual periods. Also explore Bundamedik Tbk PT (BMHS) equity growth momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Bundamedik Tbk PT (2018–2025)
Year-by-year debt coverage analysis for Bundamedik Tbk PT. For market capitalisation and broader financial context, see Bundamedik Tbk PT (BMHS) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (IDR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.15x | Rp250.62 Billion | Rp1.62 Trillion | ▲ +490.5% |
| 2024 | 0.03x | Rp33.98 Billion | Rp1.30 Trillion | ▼ -34.7% |
| 2023 | 0.04x | Rp51.44 Billion | Rp1.28 Trillion | ▼ -80.9% |
| 2022 | 0.21x | Rp237.47 Billion | Rp1.13 Trillion | ▼ -39.8% |
| 2021 | 0.35x | Rp349.44 Billion | Rp1.00 Trillion | ▲ +104.1% |
| 2020 | 0.17x | Rp190.36 Billion | Rp1.11 Trillion | ▲ +40.2% |
| 2019 | 0.12x | Rp89.72 Billion | Rp735.16 Billion | ▲ +97.6% |
| 2018 | 0.06x | Rp43.79 Billion | Rp708.92 Billion | — |